author-photo

Rana Sullivan

University of Texas MD Anderson Cancer Center

3

Papers

283

Citations

Citation Trend

Filter By

Papers (3) Sort By

Journal Conference Others

Phase I study of isotype-selective histone deacetylase (HDAC) inhibitor MGCD0103 given as three-times weekly oral dose in patients (pts) with advanced solid tumors

2016 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (10)
Phase I Study of MGCD0103 Given As a Three-Times-Per-Week Oral Dose in Patients With Advanced Solid Tumors

2008 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (110)
Phase I Dose Escalation and Pharmacokinetic Study of Enzastaurin, an Oral Protein Kinase C Beta Inhibitor, in Patients With Advanced Cancer

2006 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (163)